相关实验视频
Updated: Jun 16, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
255
微RNA及其对骨髓缩症的特征的调节作用
William J Silva1, André Cruz1, Gustavo Duque2,3
1Department of Research and Development, Mirscience Therapeutics, São Paulo, Brazil.
Current osteoporosis reports
|August 20, 2024
概括
这篇综述强调了参与骨和肌肉受影响的骨质沙症的微RNA (miRNAs). 像miR-29b,miR-128和miR-21这样的特定miRNA显示有害的作用,而miR-199b和miR-672则提供治疗潜力.
科学领域:
- 老年学是指老年学的学科.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 骨髓缩症是一种老年综合征,其特点是同时发生骨和肌肉衰退,导致残疾和死亡.
- 这种情况涉及骨和肌肉组织之间的复杂交叉声,细胞信号通路被破坏,影响骨重塑和肌肉再生.
- 微RNAs (miRNAs) 越来越多地被认为是骨髓硬化症病变的关键调节者.
研究的目的:
- 审查关键的microRNAs调节的标志性标志的肉类和骨质疏松症.
- 为了确定骨质疏松症病理学中常见的分子成分和治疗点.
- 了解这些成分如何影响骨和骨肌肉中的关键细胞过程.
主要方法:
- 文献综述总结了当前关于微RNA在骨髓瘤病变发生中的作用的证据.
- 鉴定和分析涉及疾病的特定微RNA.
- 评估已识别的microRNA点的治疗潜力.
主要成果:
- 失调的microRNAs显著促进了骨质缩症的发展.
- 微RNAs-29b和-128被上调,抑制IGF-1和SIRT1,这表明潜在的抑制剂的发展.
- 微RNA-21与肌肉和骨质损失有关;miR-199b是下调的,可能会增加肌态素和GSK3β活性,表明需要功能恢复.
- 微RNA-672对骨肌肉和骨产生保护作用,突出显示了其治疗前景.
结论:
- 特定的microRNAs在骨髓缩症的发病过程中起着至关重要的作用.
- 针对像miR-29b,miR-128,miR-199b和miR-672这样的microRNA,为骨质疏松症提供了潜在的治疗策略.
- 为了有效的治疗开发,需要对常见的microRNA标进行进一步的研究.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K

